Condition
Placenta Accreta Spectrum clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Placenta Accreta Spectrum clinical trials that are recruiting, at sites in 4 countries (most in Egypt (2), China (2), Colombia (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Placenta Accreta Spectrum clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Vision Transformer–based ultrasound AI to detect placenta accreta spectrum | — | Guangzhou, Guangdong | Recruiting | Jun 11, 2026 |
| Three conservative surgeries for placenta accreta spectrum: a comparison | — | Asyut | Recruiting | Apr 9, 2026 |
| Planned cesarean at 37 weeks versus 36 weeks for pregnancies with placenta previa and accreta | — | Guangzhou, Guangdong and 5 other locations | Recruiting | Jun 18, 2025 |
| High versus low segmental hysterotomy and uterine scar defects after a first cesarean | — | Cali, Valle del Cauca Department | Recruiting | Oct 1, 2024 |
| Managing placenta accreta spectrum while preserving the uterus | — | Philadelphia, Pennsylvania | Recruiting | Jul 22, 2024 |
| Outcomes of Uterine Conservation in Placenta Accreta Spectrum | — | Alexandria, Alexandria Governorate | Recruiting | Apr 30, 2021 |
All recruiting trials (6)
-
Vision Transformer–based ultrasound AI to detect placenta accreta spectrum
A AI tool uses ultrasound video inputs to help see if the placenta is abnormally attached during pregnancy in women at risk.
-
Three conservative surgeries for placenta accreta spectrum: a comparison
Researchers compare three uterus-preserving surgical options to see which works best for placenta accreta spectrum.
-
Planned cesarean at 37 weeks versus 36 weeks for pregnancies with placenta previa and accreta
We will test whether scheduling cesarean delivery at 37 weeks instead of 36 weeks helps newborns without increasing maternal bleeding in pregnant women with placenta previa and accreta.
-
High versus low segmental hysterotomy and uterine scar defects after a first cesarean
We will test whether high or low segmental hysterotomy, with or without cross-suturing, leads to fewer uterine scar defects in people having their first cesarean.
-
Managing placenta accreta spectrum while preserving the uterus
This study is testing a new way to manage placenta accreta spectrum disorders by allowing some women to keep their uterus after delivery instead of having surgery, to see if it can be a safer option for them.
-
Outcomes of Uterine Conservation in Placenta Accreta Spectrum
This study looks at how well uterine conservation procedures work for women with placenta accreta spectrum by tracking their recovery, blood loss, and menstrual return after the surgery.
Related topics
Quick answers
How many Placenta Accreta Spectrum clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Egypt (2 trials), China (2 trials), Colombia (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.